However, the deletion of IKKβ in myeloid cells significantly decreased the tumor size, thus demonstrating that the specific inactivation or pharmacological inhibition of IKKβ in different cell types can effectively treat CAC [248]. The gene discussed is IKBKB; the disease is neoplasm.